The Global Sinus Dilation Devices Market is expected to grow at a CAGR of 8% during the forecasting period (2020-2027).
Chronic sinusitis and related conditions are dominant medical problem worldwide. Over-the-counter drugs account for much of the expense, yet provide minimal benefit in most patients with chronic sinusitis.
Sinus dilation devices are used in the surgical treatment of sinus disease. The satisfactory results of these devices in patients with chronic sinusitis have increased its adoption in recent years.
The global market for Sinus Dilation Devices is primarily driven by the high prevalence of chronic sinusitis and a growing preference for minimally invasive surgeries.
Other actors driving the market are technological advancements in sinusitis treatments and benefits of balloon sinus dilation over conventional operations. Favorable reimbursement scenarios growing healthcare market in emerging economies act as opportunities for the global sinus dilation devices market.
However, the low preference for sinus surgical procedures due to the presence of sinusitis drugs may hinder market progress.
By Product, the global Sinus Dilation Devices market is segmented into balloon sinus dilation devices, sinuscopes, rhinoscopes, sinus stents/implants, and handheld instruments.
The balloon sinus dilation devices share holds the most significant share is attributing to the high precision of the device. The balloon dilation devices offer maximum access control and operational flexibility over sinus.
The market share is expected to further show a surge in demand with the integration of advanced technologies. Handheld instruments share estimated to show the highest growth owing it to its use as support and visualization aid during sinus dilation procedures.
By Procedure Type, the global Sinus Dilation Devices market is segmented into standalone sinus dilation procedures and hybrid sinus dilation procedures.
Standalone procedures hold a significant share of the market segment owing to benefits offered by the methods such as quick relief and reduction in long-lasting cold symptoms.
Moreover, the procedure has a high adoption rate in geriatric patients as it has minimal surgical complications which further favor the share growth.
Hybrid sinus dilation procedures share projected to show the fastest growth owing it to procedural benefits offered over the conventional methods which in turn increase its adoption in coming years.
By Patient Type, the global Sinus Dilation Devices market is segmented into adult and pediatrics. The adult segment holds the maximum share of this market owing it to a higher prevalence of sinusitis among adults. According to the Centers for Disease Controls and Prevention (CDC), viral sinusitis was more common among adults than it is in children.
North America is the dominant share in the global Sinus Dilation Devices market, and it is primarily attributed to factors such as surging incidence of chronic sinusitis in the region and good reimbursement scenario for specific sinus procedures.
Moreover, its broad base of the patient population, demand for efficient and technologically advanced and the established healthcare infrastructure, rising disposable income and higher investment in R&D activities contribute to the growth of North America’s share.
Asia-Pacific region is expected to be the fastest growing market during the forecast period, owing to the region’s rapidly improving healthcare infrastructure and the presence of a broad base of the target population.
According to the study conducted by the Indian Council of Medical Research, 2017, roughly 15% population of India was affected by chronic sinusitis.
Moreover, increasing awareness regarding minimally invasive sinus dilation procedures among the patient population further accelerate Asia Pacific regional growth.
Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.
April 2018, Intersect ENT, a company dedicated to transforming care for patients with ear, nose and throat conditions, announced U.S. commercial availability of the SINUVA (mometasone furoate) Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery.
April 2017, Olympus Corporation entered into a definitive contract to acquire Image Stream Medical, Inc. to improve medical solution assistance to healthcare facilities.
December 2017, Intersect ENT had received FDA approval for the SINUVA (mometasone furoate) Sinus Implant.
December 2017, Stryker acquired Entellus, a pioneer in providing minimally invasive technologies that enable procedures to be performed in more cost-effective sites of service in the space of sinus dilation.
July 2016, Acclarent, Inc. launched multi-sinus dilation system RELIEVA SCOUT, in the U.S.
2015, launch of XprESS LoProfile Multi-Sinus Dilation System happened in Europe.
• Visualize the composition of the global Sinus Dilation Devices Market across each indication, in terms of type and treatment options, highlighting the critical commercial assets and players.
• Identify business opportunities in global Sinus Dilation Devices Market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of the worldwide Sinus Dilation Devices Market – level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the principal products of all major market players
• Equipment Suppliers/ Buyers
• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
1. Sinus Dilation Devices Market Scope and Methodology
1.1. Research Methodology
1.2. Scope of the market
2. Sinus Dilation Devices Market Industry Trends
2.1. Key Trends and Developments
3. Sinus Dilation Devices Market Outlook
3.3. Supply Chain Analysis
3.5. Key Developments
4. Market Segmentation Analysis
4.1. By Product
4.1.1. Balloon Sinus Dilation Devices
4.1.4. Sinus Stents/Implants
4.1.5. Handheld Instruments
4.2. By Procedure Type
4.2.1. Standalone Sinus Dilation Procedures
4.2.2. Hybrid Sinus Dilation Procedures
4.3. By Patient Type
4.4. By End-user
4.4.2. Ambulatory Surgical Centers
5. Regional, Country-level Analysis
5.1. Geographic Overview
5.2. North America
5.3.4. Rest of Europe
5.4. South America
5.4.3. Rest of South America
5.5. Asia Pacific
5.5.5. Rest of Asia Pacific
5.6. Rest of World
6. Competitive Analysis
6.1. Competitive Scenario
6.2. Key Strategies adopted by Manufacturers
6.3. Product Benchmarking
7. Company Profiles
7.1. Medtronic PLC
7.2. Smith & Nephew PLC
7.3. Acclarent, Inc. (subsidiary of Johnson & Johnson)
7.4. Intersect ENT, Inc.
7.5. Entellus Medical, Inc. (subsidiary of Stryker)
7.6. Olympus Corporation
7.7. SinuSys Corporation
8.2. List of Tables
8.3. Expert Panel Validation
8.5. Contact Us
Get your FREE SAMPLE PROPOSAL with a single click!